Similar to the comparison between ATPIII(−) PCOS and ATPIII(−) control patients (Table S3), the difference in irisin level between lean PCOS and lean control patients was on the border of significance (p = 0.089) (Table S4). This evidence concerns the gene FNDC5 and polycystic ovary syndrome.